- NEGATIVE
Quarterly Revenue Unichem Laboratories Jun-2026 Quarterly Revenue is Rs 383 Cr which is growth of -1.4% YoY.
- POSITIVE
Quarterly Net Profit Unichem Laboratories Jun-2026 Quarterly Net Profit is Rs 6 Cr which is growth of 398.9% YoY.
535.05-10.45(-1.92%)
112.1K
NSE+BSE Volume
High vol. this week
NSE 01 Oct, 2026 3:31 PM (IST)
Unichem Laboratories quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents
Unichem Laboratories quarterly results: revenue, profit, and P&L – 13 quarter history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
| Indicator | Graph | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | Jun '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 383 | 378.5 | 329.9 | 378.3 | 388.5 | 467.3 | 466.8 | 444 | 398.5 | 406.3 | 372.4 | 341.4 | 352.5 | ||
Operating Exp. | 345.6 | 343.8 | 313.5 | 349.2 | 358.5 | 386.3 | 373.6 | 372.4 | 349.6 | 368.7 | 343.1 | 341.1 | 338.4 | |
Operating Profit | 20.6 | 12.5 | 1.4 | 7.7 | 25.7 | 75 | 74.2 | 64.5 | 40.2 | 30.6 | 19.3 | -7.3 | 8.3 | |
Operating Profit Margin % | 5.64% | 3.51% | 0.44% | 2.16% | 6.70% | 16.26% | 16.57% | 14.76% | 10.31% | 7.66% | 5.33% | -2.19% | 2.40% | |
Depr. | 28.7 | 29 | 30 | 30.1 | 29.9 | 27.5 | 28.5 | 26.4 | 26.1 | 25.2 | 25.6 | 27.3 | 27.4 | |
Interest | 1.3 | 4.1 | 2.1 | 3.7 | 1.9 | 1.5 | 2.9 | 1.8 | 1.4 | 1.8 | 2.4 | 3.8 | 2.5 | |
Profit Before Tax | 7.4 | -10.7 | 259.8 | -37.8 | -1.9 | 56 | 61.8 | 43.4 | 21.5 | -115 | 69.3 | -30.8 | -15.7 | |
Tax | 1.9 | 4.7 | 43.7 | 2.1 | -0 | 4.8 | 14.9 | |||||||
Net Profit | 5.5 | -15.4 | 216.1 | -39.9 | -1.9 | 51.2 | 46.9 | 43.4 | 21.5 | -115 | 69.3 | -30.8 | -15.7 | |
EPS Adj. latest | 0.8 | -2.2 | 30.7 | -5.7 | -0.3 | 7.3 | 6.7 | 6.2 | 3.1 | -16.3 | 9.8 | -4.4 | -2.2 | |
Net profit TTM | 166.3 | 158.9 | 225.6 | 56.3 | 139.6 | 163 | -3.2 | 19.2 | -55 | -92.2 | -121.1 | -247.5 | -292.1 | |
Basic EPS TTM | 23.6 | 22.6 | 32 | 8 | 19.8 | 23.2 | -0.5 | 2.7 | -7.8 | -13.1 | -17.2 | -35.2 | -41.5 | |
Results PDF | ||||||||||||||
Result Notes |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Unichem Laboratories competitor comparison and performance snapshot within industry
Unichem Laboratories annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- NEGATIVE
Annual Revenue Unichem Laboratories Mar-2026 Annual Revenue is Rs 1,475 Cr which is growth of -17.0% YoY.
- NEGATIVE
Annual Net Profit Unichem Laboratories Mar-2026 Annual Net Profit is Rs 159 Cr which is growth of -2.5% YoY.
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
-17%
2Y CAGR
0.1%
3Y CAGR
9.8%
5Y CAGR
4.7%
7Y CAGR
4.7%
10Y CAGR
1.7%
Total Revenue Annual is falling faster than historical averages.
Net Profit Ann.
1Y CHG
-2.5%
5Y CAGR
24%
7Y CAGR
51.2%
10Y CAGR
4.7%
Net Profit Annual is falling faster than historical averages.
Operating Exp. Ann.
1Y CHG
-8.1%
2Y CAGR
-1.1%
3Y CAGR
5.3%
5Y CAGR
5.8%
7Y CAGR
4.1%
10Y CAGR
2.3%
Operating Expenses Annual Cr is falling faster than historical averages.
Unichem Laboratories balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Total Shareholders Fund Unichem Laboratories Mar-2026 Total Shareholders Fund is Rs 2,627 Cr which is growth of 6.8% YoY.
- NEGATIVE
Total Assets Unichem Laboratories Mar-2026 Total Assets is Rs 3,092 Cr which is growth of -0.5% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3.3% | -0.5% | 2,627.1 | 2,459.8 | 2,294.6 | 2,384.3 | 2,672 | 2,697.3 | 2,647.2 | 2,731.9 | 2,761.7 | 1,130.7 | 1,027.1 | ||
Minority Interest Liability Ann. | - | - | - | - | - | - | - | - | - | - | - | - | - | |
9.9% | 24.5% | 150.4 | 129.9 | 81.1 | 113.2 | 139.6 | 50.3 | 29.7 | 26.8 | 45.4 | 70.4 | 63.7 | ||
-6.8% | -3.2% | 315 | 519.5 | 487.9 | 388.7 | 310.4 | 371.5 | 348.3 | 271.5 | 295.9 | 301.8 | 250.7 | ||
Total Capital Plus Liabilities Ann. | 2.3% | -0.2% | 3,092.5 | 3,109.2 | 2,863.7 | 2,886.1 | 3,122.1 | 3,119.1 | 3,025.1 | 3,030.2 | 3,102.9 | 1,502.9 | 1,341.6 | |
-2.3% | -1.9% | 1,290 | 1,305.7 | 1,287.3 | 1,383.8 | 1,457.3 | 1,417.5 | 1,159.4 | 879.1 | 790.4 | 715.2 | 613.9 | ||
-0.7% | -3% | 1,555.6 | 1,533.4 | 1,454.2 | 1,590 | 1,748.1 | 1,813.7 | 1,520.4 | 1,177.1 | 895.6 | 815.7 | 746.7 | ||
5.8% | 3.3% | 1,536.9 | 1,575.9 | 1,409.5 | 1,296.2 | 1,374 | 1,305.4 | 1,504.7 | 1,853.1 | 2,207.4 | 687.3 | 594.9 | ||
Total Assets Ann. | 2.3% | -0.2% | 3,092.5 | 3,109.2 | 2,863.7 | 2,886.1 | 3,122.1 | 3,119.1 | 3,025.1 | 3,030.2 | 3,102.9 | 1,502.9 | 1,341.6 | |
Contingent Liabilities plus Commitments Ann. | 29.5% | 15.9% | 651.9 | 266.9 | 105.2 | 300.5 | 294.4 | 311.3 | 521.6 | 673.2 | 422.4 | 231 | ||
Bonus Equity Share Capital Ann. | 0% | 0% | 11.4 | 11.4 | 11.4 | 11.4 | 11.4 | 11.4 | 11.4 | 11.4 | 11.4 | 14.7 | 14.7 | |
Non Current Investments Unquoted Book Value Ann. | 7% | -30.1% | 47.5 | 45.6 | 42.7 | 38.8 | 126 | 283.8 | 249.1 | 241.6 | 83.2 | 81.3 | 102.4 | |
Current Investments Unquoted Book Value Ann. | - | - | 0.3 | 8 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Total Assets Ann.
1Y CHG
-0.5%
2Y CAGR
3.9%
3Y CAGR
2.3%
5Y CAGR
-0.2%
7Y CAGR
0.3%
10Y CAGR
8.7%
Total Assets Annual is falling faster than historical averages.
Total Current Liabilities Ann.
1Y CHG
-39.4%
2Y CAGR
-19.6%
3Y CAGR
-6.8%
5Y CAGR
-3.2%
7Y CAGR
2.1%
10Y CAGR
2.3%
Total Current Liabilities Annual Cr is falling faster than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
6.8%
2Y CAGR
7%
3Y CAGR
3.3%
5Y CAGR
-0.5%
7Y CAGR
-0.6%
10Y CAGR
9.8%
Total ShareHolders Funds Annual growth is higher than historical averages.
Unichem Laboratories ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Book Value Per Share Unichem Laboratories Mar-2026 Book Value Per Share is 373 Rs which is growth of 6.8% YoY.
- POSITIVE
ROE Unichem Laboratories Mar-2026 ROE is 6% which is growth of 0.6% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BVSH Ann. | 3.3% | -0.5% | 373.2 | 349.4 | 325.9 | 338.7 | 379.5 | 383.1 | 376 | 388.2 | 392.6 | 124.4 | 113.1 | |
RoA Ann. % | - | 24.3% | 5.13% | 5.24% | -3.21% | -10.38% | -1.77% | 1.73% | -1.86% | 0.29% | 82.39% | 6.91% | 7.49% | |
ROE Ann. % | - | 24.8% | 6.05% | 6.62% | -4.01% | -12.56% | -2.07% | 2.00% | -2.12% | 0.32% | 92.57% | 9.18% | 9.79% | |
ROCE Ann. % | - | - | -0.20% | 7.19% | -1.01% | -6.28% | -3.01% | 2.43% | -2.33% | -0.75% | -4.21% | -7.51% | 11.92% | |
Total Debt to Total Equity Ann. | 0 | 0.1 | 0 | 0 | 0.1 | 0 | 0 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
ROE Ann. %
1Y CHG
-8.6%
5Y CAGR
24.8%
7Y CAGR
52.2%
10Y CAGR
-4.7%
ROE Annual % is falling faster than historical averages.
RoA Ann. %
1Y CHG
-2.1%
5Y CAGR
24.3%
7Y CAGR
50.7%
10Y CAGR
-3.7%
RoA Annual % is falling faster than historical averages.
Current Ratio Ann.
1Y CHG
63.3%
2Y CAGR
30%
3Y CAGR
14.1%
5Y CAGR
7%
7Y CAGR
-4.6%
10Y CAGR
7.4%
Current Ratio Annual growth is higher than historical averages.
Unichem Laboratories cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history
Nested row level
Base Level
Reporting Type
Standalone
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- NEGATIVE
Cash From Operating Activity Unichem Laboratories Mar-2026 Cash From Operating Activity is Rs 53 Cr which is growth of -27.2% YoY.
- POSITIVE
Net Cash Flow Unichem Laboratories Mar-2026 Net Cash Flow is Rs 190 Cr which is growth of 394.7% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
- | - | 52.6 | 72.3 | -41.6 | -117.3 | -158.3 | -32.5 | -41.8 | -251.3 | -66.3 | 140.8 | 116.6 | ||
Cash from Investing Act. Ann. | 0.9% | - | 207.8 | -132.1 | 53.2 | 202.5 | 104 | -80.4 | -35.6 | -322.6 | 1,648.6 | -131.9 | -86.7 | |
Cash from Financing Act. Ann. | - | - | -70.7 | -4.6 | -48.1 | -61.8 | 95.8 | -45.2 | -21 | -44.9 | -929.5 | -9 | -38.6 | |
100.9% | - | 189.8 | -64.4 | -36.4 | 23.4 | 41.5 | -158.1 | -98.5 | -618.8 | 652.9 | -0.1 | -8.8 |
*All financials are in INR Cr and price data in INR
Add metric to table
Search...
Cash from Operating Act. Ann.
1Y CHG
-27.2%
10Y CAGR
-7.7%
Cash from Operating Activity Annual is falling faster than historical averages.
Cash from Investing Act. Ann.
2Y CAGR
97.6%
3Y CAGR
0.9%
Cash from Investing Activity Annual growth is higher than historical averages.
